2 mars 2021, visio conférence en anglais

COVID-19 Vaccine AstraZeneca EU Webcast

Horaires : 19h-20h15 CET (Central European Time)

Safety and efficacy of COVID-19 Vaccine AstraZeneca:a vaccine approved for SARS-CoV-2 in Europe

Programme :

  • Welcome and introduction Iskra Reic (AstraZeneca) / Tobias Welte (Germany)
  • The fight against SARS-CoV-2:the vaccine landscape in Europe
    Tobias Welte (Germany)
  • Conducting clinical trials during a pandemic:the COVID-19 Vaccine AstraZeneca story
    Hugo Gomes da Silva (AstraZeneca)
  • Safety, efficacy and immunogenicity of COVID-19 Vaccine AstraZeneca
    Hugo Gomes da Silva (AstraZeneca)
  • Vaccine rollout : key learnings, best practice and future perspectives
    Kirsty Le Doare (UK)
  • Meeting close
    Tobias Welte


PDF - 825.4 ko

Inscription :